{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33525"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33525","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Bridging the Gap in Female Muscle and Exercise Physiology","abstract":"Females have been underrepresented in exercise physiology research, leaving the evidence base for premenopausal resistance exercise training (RET) recommendations inadequate. In this vacuum, menstrual cycle (MC)-based training recommendations proliferated, asserting that the follicular phase represents an anabolic window and the luteal phase a catabolic one. These claims were derived from studies with unverified hormonal status, mismatched training volumes, and inappropriate methodologies. This dissertation addressed that evidentiary gap through integrated review, methodological, and experimental investigations in premenopausal females. Chapters 1 and 2 reviewed the physiological effects of MC hormones and oral contraceptives on exercise-related outcomes and critically evaluated the rationale for endogenous ovarian hormones as regulators of RET-induced hypertrophy. Both reviews concluded that existing evidence was insufficient to support MC-based recommendations. Chapter 3 established a methodological framework for studying skeletal muscle remodelling in females, integrating molecular, stable isotope tracer-derived, and body composition measures across timescales of adaptation. Chapter 4 reports the first application of the COSIAM protocol in premenopausal females (n = 21), simultaneously quantifying myofibrillar protein synthesis (MyoPS), myofibrillar protein breakdown, and skeletal muscle mass (SMM). These data also demonstrated that commonly used body composition methods substantially misestimate SMM in females. Chapter 5 employed a randomized, double-blind, placebo-controlled stable isotope tracer infusion design (n = 20) to determine whether progesterone alters MyoPS. Progesterone did not suppress MyoPS at rest, following protein feeding, or following resistance exercise. Chapter 6 extended these findings to a randomized controlled trial (n = 24) comparing follicular-phase, luteal-phase, and continuous RET across three LH surge-monitored MCs. MC phase-based RET periodization conferred no advantage in lean mass or strength. Collectively, progesterone does not alter MyoPS, and MC phase does not meaningfully regulate skeletal muscle adaptation to RET in premenopausal females. These findings help close an evidentiary gap and establish methodological standards for future female-specific research.","abstract_html":"Females have been underrepresented in exercise physiology research, leaving the evidence base for premenopausal resistance exercise training (RET) recommendations inadequate. In this vacuum, menstrual cycle (MC)-based training recommendations proliferated, asserting that the follicular phase represents an anabolic window and the luteal phase a catabolic one. These claims were derived from studies with unverified hormonal status, mismatched training volumes, and inappropriate methodologies. This dissertation addressed that evidentiary gap through integrated review, methodological, and experimental investigations in premenopausal females. Chapters 1 and 2 reviewed the physiological effects of MC hormones and oral contraceptives on exercise-related outcomes and critically evaluated the rationale for endogenous ovarian hormones as regulators of RET-induced hypertrophy. Both reviews concluded that existing evidence was insufficient to support MC-based recommendations. Chapter 3 established a methodological framework for studying skeletal muscle remodelling in females, integrating molecular, stable isotope tracer-derived, and body composition measures across timescales of adaptation. Chapter 4 reports the first application of the COSIAM protocol in premenopausal females (n = 21), simultaneously quantifying myofibrillar protein synthesis (MyoPS), myofibrillar protein breakdown, and skeletal muscle mass (SMM). These data also demonstrated that commonly used body composition methods substantially misestimate SMM in females. Chapter 5 employed a randomized, double-blind, placebo-controlled stable isotope tracer infusion design (n = 20) to determine whether progesterone alters MyoPS. Progesterone did not suppress MyoPS at rest, following protein feeding, or following resistance exercise. Chapter 6 extended these findings to a randomized controlled trial (n = 24) comparing follicular-phase, luteal-phase, and continuous RET across three LH surge-monitored MCs. MC phase-based RET periodization conferred no advantage in lean mass or strength. Collectively, progesterone does not alter MyoPS, and MC phase does not meaningfully regulate skeletal muscle adaptation to RET in premenopausal females. These findings help close an evidentiary gap and establish methodological standards for future female-specific research.","abstract_has_math":false,"creators":["D'Souza, Alysha C."],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Kinesiology","school":null,"contributors":[],"advisors":["Phillips, Stuart"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:38:29Z","subjects":["Female","Muscle","MEDICINE::Physiology and pharmacology::Physiology","Exercise","Resistance exercise","Menstrual cycle","Progesterone"],"languages":["en"],"rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"rights_urls":["http://creativecommons.org/licenses/by-nc-nd/4.0/"],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/2309"],"render_values":[{"text":"https://doi.org/10.71548/2309","href":"https://doi.org/10.71548/2309","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33525","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33525","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33525","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Phillips, Stuart"]},{"key":"dc:contributor.department","label":"Department","values":["Kinesiology"]},{"key":"dc:creator","label":"Author","values":["D'Souza, Alysha C."]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-09-01T14:46:18Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Dissertation","Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Female","Muscle","MEDICINE::Physiology and pharmacology::Physiology","Exercise","Resistance exercise","Menstrual cycle","Progesterone"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]},{"key":"dc:rights","label":"Dc Rights","values":["Attribution-NonCommercial-NoDerivatives 4.0 International"]},{"key":"dc:rights.uri","label":"Rights URI","values":["http://creativecommons.org/licenses/by-nc-nd/4.0/"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33525","https://doi.org/10.71548/2309"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["LAY ABSTRACT: For years, females have been told that their menstrual cycle should shape how they train. The follicular phase, the first half of the cycle, was described as the body's anabolic window, a time when muscle could be built more efficiently. The luteal phase, the second half, was cast as hormonally catabolic, a period during which training should be reduced and recovery prioritized. These recommendations reached millions of females through social media, books, and coaching guidance. What they lacked was solid scientific evidence. This dissertation set out to build that evidence. Using gold-standard measurement tools, including stable isotope tracer techniques that directly measure the rate at which muscle protein is built, best-practices for tracking the menstrual cycle, and supervised strength training programs, this research investigated whether the hormonal fluctuations of the menstrual cycle actually change the way muscle responds to muscle strengthening exercise and whether timing training to a specific menstrual cycle phase produces better results. The findings are clear: progesterone, the hormone most frequently blamed for suppressing muscle building during the luteal phase, does not alter muscle protein synthesis, even when elevated to concentrations well above normal luteal phase levels. Additionally, when females trained with high volumes in the follicular phase, the luteal phase, or consistently across both, they gained the same amount of muscle and strength. Menstrual cycle symptoms are real, and good coaching practices accounts for that. However, this new body of evidence highlights that females have the capacity to adapt robustly to strength training, regardless of where they are in the menstrual cycle."]},{"key":"dc:description.abstract","label":"Abstract","values":["Females have been underrepresented in exercise physiology research, leaving the evidence base for premenopausal resistance exercise training (RET) recommendations inadequate. In this vacuum, menstrual cycle (MC)-based training recommendations proliferated, asserting that the follicular phase represents an anabolic window and the luteal phase a catabolic one. These claims were derived from studies with unverified hormonal status, mismatched training volumes, and inappropriate methodologies. This dissertation addressed that evidentiary gap through integrated review, methodological, and experimental investigations in premenopausal females. Chapters 1 and 2 reviewed the physiological effects of MC hormones and oral contraceptives on exercise-related outcomes and critically evaluated the rationale for endogenous ovarian hormones as regulators of RET-induced hypertrophy. Both reviews concluded that existing evidence was insufficient to support MC-based recommendations. Chapter 3 established a methodological framework for studying skeletal muscle remodelling in females, integrating molecular, stable isotope tracer-derived, and body composition measures across timescales of adaptation. Chapter 4 reports the first application of the COSIAM protocol in premenopausal females (n = 21), simultaneously quantifying myofibrillar protein synthesis (MyoPS), myofibrillar protein breakdown, and skeletal muscle mass (SMM). These data also demonstrated that commonly used body composition methods substantially misestimate SMM in females. Chapter 5 employed a randomized, double-blind, placebo-controlled stable isotope tracer infusion design (n = 20) to determine whether progesterone alters MyoPS. Progesterone did not suppress MyoPS at rest, following protein feeding, or following resistance exercise. Chapter 6 extended these findings to a randomized controlled trial (n = 24) comparing follicular-phase, luteal-phase, and continuous RET across three LH surge-monitored MCs. MC phase-based RET periodization conferred no advantage in lean mass or strength. Collectively, progesterone does not alter MyoPS, and MC phase does not meaningfully regulate skeletal muscle adaptation to RET in premenopausal females. These findings help close an evidentiary gap and establish methodological standards for future female-specific research."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Doctor of Philosophy (PhD)"]},{"key":"dc:description.sponsorship","label":"Dc Description Sponsorship","values":["N/A"]},{"key":"dc:title","label":"Title","values":["Bridging the Gap in Female Muscle and Exercise Physiology"]},{"key":"dc:title.alternative","label":"Alternative Title","values":["Advancing Female Skeletal Muscle Physiology"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["Phillips, Stuart"],"dc:contributor.department":["Kinesiology"],"dc:creator":["D'Souza, Alysha C."],"dc:date.accessioned":["2026-09-01T14:46:18Z"],"dc:date.issued":["2026"],"dc:description":["LAY ABSTRACT: For years, females have been told that their menstrual cycle should shape how they train. The follicular phase, the first half of the cycle, was described as the body's anabolic window, a time when muscle could be built more efficiently. The luteal phase, the second half, was cast as hormonally catabolic, a period during which training should be reduced and recovery prioritized. These recommendations reached millions of females through social media, books, and coaching guidance. What they lacked was solid scientific evidence. This dissertation set out to build that evidence. Using gold-standard measurement tools, including stable isotope tracer techniques that directly measure the rate at which muscle protein is built, best-practices for tracking the menstrual cycle, and supervised strength training programs, this research investigated whether the hormonal fluctuations of the menstrual cycle actually change the way muscle responds to muscle strengthening exercise and whether timing training to a specific menstrual cycle phase produces better results. The findings are clear: progesterone, the hormone most frequently blamed for suppressing muscle building during the luteal phase, does not alter muscle protein synthesis, even when elevated to concentrations well above normal luteal phase levels. Additionally, when females trained with high volumes in the follicular phase, the luteal phase, or consistently across both, they gained the same amount of muscle and strength. Menstrual cycle symptoms are real, and good coaching practices accounts for that. However, this new body of evidence highlights that females have the capacity to adapt robustly to strength training, regardless of where they are in the menstrual cycle."],"dc:description.abstract":["Females have been underrepresented in exercise physiology research, leaving the evidence base for premenopausal resistance exercise training (RET) recommendations inadequate. In this vacuum, menstrual cycle (MC)-based training recommendations proliferated, asserting that the follicular phase represents an anabolic window and the luteal phase a catabolic one. These claims were derived from studies with unverified hormonal status, mismatched training volumes, and inappropriate methodologies. This dissertation addressed that evidentiary gap through integrated review, methodological, and experimental investigations in premenopausal females. Chapters 1 and 2 reviewed the physiological effects of MC hormones and oral contraceptives on exercise-related outcomes and critically evaluated the rationale for endogenous ovarian hormones as regulators of RET-induced hypertrophy. Both reviews concluded that existing evidence was insufficient to support MC-based recommendations. Chapter 3 established a methodological framework for studying skeletal muscle remodelling in females, integrating molecular, stable isotope tracer-derived, and body composition measures across timescales of adaptation. Chapter 4 reports the first application of the COSIAM protocol in premenopausal females (n = 21), simultaneously quantifying myofibrillar protein synthesis (MyoPS), myofibrillar protein breakdown, and skeletal muscle mass (SMM). These data also demonstrated that commonly used body composition methods substantially misestimate SMM in females. Chapter 5 employed a randomized, double-blind, placebo-controlled stable isotope tracer infusion design (n = 20) to determine whether progesterone alters MyoPS. Progesterone did not suppress MyoPS at rest, following protein feeding, or following resistance exercise. Chapter 6 extended these findings to a randomized controlled trial (n = 24) comparing follicular-phase, luteal-phase, and continuous RET across three LH surge-monitored MCs. MC phase-based RET periodization conferred no advantage in lean mass or strength. Collectively, progesterone does not alter MyoPS, and MC phase does not meaningfully regulate skeletal muscle adaptation to RET in premenopausal females. These findings help close an evidentiary gap and establish methodological standards for future female-specific research."],"dc:description.degree":["Doctor of Philosophy (PhD)"],"dc:description.sponsorship":["N/A"],"dc:identifier.uri":["https://hdl.handle.net/11375/33525","https://doi.org/10.71548/2309"],"dc:language.iso":["en"],"dc:rights":["Attribution-NonCommercial-NoDerivatives 4.0 International"],"dc:rights.uri":["http://creativecommons.org/licenses/by-nc-nd/4.0/"],"dc:subject":["Female","Muscle","MEDICINE::Physiology and pharmacology::Physiology","Exercise","Resistance exercise","Menstrual cycle","Progesterone"],"dc:title":["Bridging the Gap in Female Muscle and Exercise Physiology"],"dc:title.alternative":["Advancing Female Skeletal Muscle Physiology"],"dc:type":["Dissertation","Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:38:29Z"}